RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 78 filers reported holding RUBIUS THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $79,000 | -43.6% | 14,367 | 0.0% | 0.00% | – |
| Q4 2021 | $140,000 | -45.1% | 14,367 | +0.8% | 0.00% | – |
| Q3 2021 | $255,000 | +64.5% | 14,260 | +123.7% | 0.00% | – |
| Q2 2021 | $155,000 | +23.0% | 6,376 | +34.3% | 0.00% | – |
| Q1 2021 | $126,000 | +231.6% | 4,747 | -5.5% | 0.00% | – |
| Q4 2020 | $38,000 | +52.0% | 5,022 | 0.0% | 0.00% | – |
| Q3 2020 | $25,000 | -35.9% | 5,022 | -22.2% | 0.00% | – |
| Q2 2020 | $39,000 | +18.2% | 6,458 | -14.1% | 0.00% | – |
| Q1 2020 | $33,000 | -59.3% | 7,521 | -11.9% | 0.00% | – |
| Q4 2019 | $81,000 | +42.1% | 8,539 | +18.2% | 0.00% | – |
| Q3 2019 | $57,000 | -49.6% | 7,222 | 0.0% | 0.00% | – |
| Q2 2019 | $113,000 | +10.8% | 7,222 | +28.6% | 0.00% | – |
| Q1 2019 | $102,000 | +240.0% | 5,615 | +204.3% | 0.00% | – |
| Q4 2018 | $30,000 | -31.8% | 1,845 | 0.0% | 0.00% | – |
| Q3 2018 | $44,000 | – | 1,845 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 38,296,526 | $290,671,000 | 5.29% |
| HARBOURVEST PARTNERS LLC | 986,878 | $7,490,000 | 2.93% |
| Abbot Financial Management, Inc. | 537,000 | $4,076,000 | 2.35% |
| Artal Group S.A. | 3,778,913 | $28,682,000 | 0.62% |
| HITE Hedge Asset Management LLC | 88,740 | $674,000 | 0.16% |
| Virtus ETF Advisers LLC | 33,793 | $256,000 | 0.11% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 394,909 | $2,997,000 | 0.03% |
| Baillie Gifford | 4,710,061 | $35,749,000 | 0.02% |
| Caption Management, LLC | 86,000 | $652,000 | 0.02% |
| Blueshift Asset Management, LLC | 14,626 | $111,000 | 0.01% |